-

2020 Global Forecast for Advanced Driver Assistance Systems - Based on Over 140 Countries Including Brazil, China & the US - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "2020 Global Forecast for Advanced Driver Assistance Systems (Adas) (2021-2026 Outlook)-High Tech & Emerging Markets Report" report has been added to ResearchAndMarkets.com's offering.

The 2020 Global Forecast for Advanced Driver Assistance Systems (Adas) (2021-2026 Outlook)-High Tech & Emerging Markets Report, contains timely and accurate market statistics and forecasts on the market for over 140 countries.

Estimates on equipment or material sales (product shipments value) are published historically for 2013 to 2017, projections for 2016 to 2020 and forecasts for 2021 to 2026. Product shipments include the total value of all products produced and shipped by all producers. For selected products, this can represent value of receipts, value of production, or value of work done. More than 140 countries are featured in this report as well as global and regional summaries. Product shipments value are presented in US Dollars and local currency units for historical and forecast years.

Published annually, this report provides a unique and accurate estimate on market sizing for this equipment/material using a proprietary economic model that integrates historical trends (horizontal analysis) and longitudinal analysis of incorporated industries (vertical analysis).

Product shipments values are also broken down by related costs, such as cost of materials, cost of fuels/electricity, contract work and value added, as well as capital expenditures, such as expenditures on buildings, machinery, vehicles and computers.

These markets are labeled as emerging market because their annual growth rate is above seven percent, which is the historical average return of the NYSE stock market. Therefore, any market, industry, investment or growth rate that exceeds the foremost investment market in the world would be considered an above average growth rate. They are also labeled high tech markets because they are new, cutting-edge markets are currently small but are projected to have extraordinary potentials in the next five years.

This report does not list key players/companies in the market but focuses on a top-down and outlook view of the market despite the existing and entering of market companies.

Manufacturing & Markets reports are an essential part of any GAP analysis, benchmarking project, SWOT analysis, business plan, risk analysis, or growth-share matrix.

Key Topics Covered:

User's Guide

Definitions and Methodology

Executive Summary

A. Global Summary

B. Regional Summary

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Africa
  • Middle East

C. Country Details

  • Argentina
  • Australia
  • Austria
  • Bangladesh
  • Belgium
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Czech Republic
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Hong Kong SAR, China
  • Hungary
  • India
  • Indonesia
  • Iran, Islamic Rep.
  • Ireland
  • Israel
  • Italy
  • Japan
  • Korea, Rep.
  • Malaysia
  • Mexico
  • Netherlands
  • New Zealand
  • Nigeria
  • Norway
  • Pakistan
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Romania
  • Russian Federation
  • Saudia Arabia
  • Singapore
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
  • United States
  • Venezuela, RB
  • Vietnam

D. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/nrsmlf

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Platinum-Based Catalysts Market Outlook to 2029 & 2034: Revenues to Reach $4.98 Billion by 2029 - Industry Leaders are Sinopec Catalyst Co., BASF, Thermo Fisher Scientific, and Linde - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Platinum-Based Catalysts Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The platinum-based catalysts market has experienced robust growth recently, with its value expected to expand from $3.67 billion in 2024 to $3.91 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. This previous growth is primarily driven by the automotive industry's demand, stricter environmental regulations, fuel cell technology adoption, and the...

Middle East Colocation Data Center Portfolio Analysis Report 2025: Khazna Data Centers, Saudi Telecom Company and Gulf Data Hub Rank Among the Leading Data Center Operators by Capacity - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Middle East Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's offering. Middle East hosts around 170+ existing data centers, with countries like the UAE & Saudi Arabia having a strong presence in the region. Khazna Data Centers, Saudi Telecom Company and Gulf Data Hub rank among the leading data center operators by capacity across Middle East. The United Arab Emirates dominates the existing market with a power ca...

CD22 Targeted Therapies Market Research Report 2025-2026: Approved Drug Sales, Technology Platforms & Clinical Trials Insights - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "CD22 Targeted Therapies Market, Approved Drug Sales, Technology Platforms & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. Report Findings & Highlights: Current & Future Global Market Outlook Insight on CD22 Targeted Approaches Approved Drug Dosage, Price & Sales Insight CD22 Targeted Therapies Development Trends by Region & Indications CD22 Targeted Therapies in Clinical Trials: > 20 Therapies CD22...
Back to Newsroom